An Imbalance of Two Functionally and Phenotypically Different Subsets of Plasmacytoid Dendritic Cells Characterizes the Dysfunctional Immune Regulation in Multiple Sclerosis

2011 ◽  
Vol 2011 ◽  
pp. 94
Author(s):  
A. Minagar
2011 ◽  
Vol 8 (1) ◽  
pp. 2 ◽  
Author(s):  
Ana Longhini ◽  
Felipe von Glehn ◽  
Carlos Brandão ◽  
Rosemeire FO de Paula ◽  
Fernando Pradella ◽  
...  

2019 ◽  
Vol 20 (11) ◽  
pp. 2811 ◽  
Author(s):  
Marta Corsetti ◽  
Gabriella Ruocco ◽  
Serena Ruggieri ◽  
Claudio Gasperini ◽  
Luca Battistini ◽  
...  

Background: Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. The cause of multiple sclerosis is unknown but there are several evidences that associate the genetic basis of the disease with environmental causes. An important association between viral infection and development of MS is clearly demonstrated. Viruses have a strong impact on innate immune cells. In particular, myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs), are able to respond to viruses and to activate the adaptive immune response. Methods: In this study we mimic viral infection using synthetic single-strand RNA, Resiquimod, and we compared the response of both DC subsets derived from healthy donors and MS patients by characterizing the expression of costimulatory molecules on the DC surface. Results: We found that pDCs from MS patients express higher levels of OX40-L, HLA-DR, and CD86 than healthy donors. Moreover, we found that blood cells from MS patients and healthy donors upon Resiquimod-stimulation are enriched in a subpopulation of pDCs, characterized by a high amount of costimulatory molecules. Conclusion: Overall, these results indicate that activation of pDCs is enhanced in MS, likely due to a latent viral infection, and that costimulatory molecules expressed on pDCs could mediate a protective response against the viral trigger of autoimmunity.


2011 ◽  
Vol 127 (2) ◽  
pp. AB228-AB228
Author(s):  
A.Y. Hancharou ◽  
L.P. Titov ◽  
I.U. Ramanava ◽  
L.M. DuBuske

2014 ◽  
Vol 275 (1-2) ◽  
pp. 207-208
Author(s):  
Gabriella Ruocco ◽  
Silvia Rossi ◽  
Caterina Motta ◽  
Giulia Macchiarulo ◽  
Francesca Barbieri ◽  
...  

Brain ◽  
2006 ◽  
Vol 129 (5) ◽  
pp. 1293-1305 ◽  
Author(s):  
Mariusz Stasiolek ◽  
Antonios Bayas ◽  
Niels Kruse ◽  
Anja Wieczarkowiecz ◽  
Klaus V. Toyka ◽  
...  

2013 ◽  
Vol 73 (5) ◽  
pp. 626-636 ◽  
Author(s):  
Valerio Chiurchiù ◽  
Maria Teresa Cencioni ◽  
Elisa Bisicchia ◽  
Marco De Bardi ◽  
Claudio Gasperini ◽  
...  

Oncotarget ◽  
2016 ◽  
Vol 7 (10) ◽  
pp. 10947-10961 ◽  
Author(s):  
Young-In Kim ◽  
Bo-Ra Lee ◽  
Jae-Hee Cheon ◽  
Bo-Eun Kwon ◽  
Mi-Na Kweon ◽  
...  

2015 ◽  
Vol 129 (4) ◽  
pp. 291-303 ◽  
Author(s):  
Gabriella Ruocco ◽  
Silvia Rossi ◽  
Caterina Motta ◽  
Giulia Macchiarulo ◽  
Francesca Barbieri ◽  
...  

We have established a novel role in multiple sclerosis for a molecule, called IL-9, produced by immune cells. IL-9 reduces inflammation, and its expression in the cerebrospinal fluid of patients inversely correlates with the severity of multiple sclerosis.


Sign in / Sign up

Export Citation Format

Share Document